Alterations in Muscle After Total Knee Arthroplasty
7 de junho de 2021 atualizado por: University of Colorado, Denver
Alterations in Skeletal Muscle Gene Expression Following Total Knee Arthroplasty
The overall goals of this work are: 1) to elucidate alterations in gene expression and downstream protein synthesis 2 weeks after Total Knee Arthroplasty (TKA) to better explain quadriceps muscle atrophy after TKA and 2) understand the mechanisms responsible for improved maintenance of muscle strength with Neuromuscular Electrical Stimulation (NMES) utilization.
Furthermore, this investigation seeks to expand previous findings regarding attenuation of strength and functional performance deficits with NMES application to better understand how altered gene expression influences muscle function.
Visão geral do estudo
Status
Concluído
Condições
Tipo de estudo
Intervencional
Inscrição (Antecipado)
20
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80045
- University of Colorado School of Medicine
-
Aurora, Colorado, Estados Unidos, 80045
- Univeristy of Colorado Anschutz Medical Campus
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
50 anos a 75 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- 50 to 75 years of age
- Scheduled for unilateral TKA at University of Colorado Hospital
- Diagnosed with osteoarthritis
- Cognitive status that allows patients to consistently comprehend and repeat back directions regarding the details of the study
Exclusion Criteria:
- Neurological, vascular or cardiac problems that significantly limit function
- BMI > 35
- Testosterone supplementation
- Pregnancy
- Anticoagulant therapy
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Neuromuscular Electrical Stimulation
Neuromuscular Electrical Stimulation (NMES) 48 hours after TKA, 5x/week, 2x/day, for 45 minutes/session. Standard Rehabilitation Protocol |
5x/week, 2x/day, for 45 minutes/session
Standard physical therapy after TKA
|
|
Comparador Ativo: Control
Standard Rehabilitation Protocol
|
Standard physical therapy after TKA
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Catabolic gene expression
Prazo: Change in gene expression from immediately pre surgery to 2 weeks after surgery
|
Standard procedures including total RNA isolation, cDNA synthesis, cRNA labeling, microarray hybridization and image acquisition will be performed.
Protein content (translation of MAFbx, MuRF1, myostatin) will be analyzed.
Total RNA (500 ng) will be reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA), and quantitative PCR will be performed using primer sets for genes of interest, reference genes and iQ SYBR Supermix (Bio-Rad) following manufacturer's protocols.
|
Change in gene expression from immediately pre surgery to 2 weeks after surgery
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in quadriceps strength
Prazo: 3 days Pre operative and 2 weeks post operative
|
Isometric quadriceps strength will be using a doublet interpolation test performed by research assistants blinded to participants' treatment randomization.
Briefly, patients will be seated and stabilized in a HUMAC NORM (Computer Sports Medicine Incorporated, Stoughton, MA) dynamometer with their knee flexed to 60 degrees.
After proper warm up, patients will be asked to perform a maximum voluntary isometric contraction of their quadriceps while receiving verbal reinforcement.
|
3 days Pre operative and 2 weeks post operative
|
|
Changes in quadriceps size
Prazo: 3 days Pre operative and 2 weeks post operative
|
Peripheral Quantitative Computed Tomography scans of the distal femur will be used to assess the changes in quadriceps muscle morphology quantitatively.
The maximal cross-sectional area of the quadriceps will be determined prior to TKA and ~14 days after TKA by manually placing the scanner at a line marked on the vastus lateralis one third of the distance between the greater trochanter and the lateral epicondyle of the femur.
The pQCT software will analyze the image and calculate muscle cross-sectional area.
A previous investigation by Cramer, et al. validated the pQCT to measurement of muscle cross-sectional area by comparison to MRI and (R2 values of 0.979 and 0.983).
In addition, the use of the pQCT to measure muscle cross sectional area had high test-retest reliability, with ICC values of 0.996 and 0.998.
|
3 days Pre operative and 2 weeks post operative
|
|
Changes in quadriceps activation
Prazo: 3 days Pre operative and 2 weeks post operative
|
Isometric quadriceps activation testing will be using a doublet interpolation test performed by research assistants blinded to participants' treatment randomization.
Briefly, patients will be seated and stabilized in a HUMAC NORM (Computer Sports Medicine Incorporated, Stoughton, MA) dynamometer with their knee flexed to 60 degrees.
After proper warm up, patients will be asked to perform a maximum voluntary isometric contraction of their quadriceps while receiving verbal reinforcement.
During the contraction, a 2 pulse, 600 µs duration/pulse, supramaximal 100Hz stimulus will be delivered to the muscle to assess whether the subject is indeed maximally contracting the quadriceps muscle and again at rest.
|
3 days Pre operative and 2 weeks post operative
|
|
Functional Performance Measures (4 meter walk test, timed up and go, stair climbing test)
Prazo: 3 days Pre operative and 2 weeks post operative
|
The timed Stair Climbing Test (SCT) places a high demand on the quadriceps and therefore measures a higher level of function and, therefore, minimizes the possibility of a ceiling effect.
The SCT has been shown to significantly correlate to the Timed Up and Go (TUG).
The TUG measures the time it takes a patient to rise from an arm chair (seat height of 46 cm), walk 3 m, turn and return to sitting in the same chair without physical assistance.25
This test has excellent inter-rater (ICC=0.99)
and intra-rater reliability (ICC=0.99),
as measured in a group of 60 functionally disabled older adults (mean age 80 years).25
The 4 meter Walk Test (4mWT) will be assessed at the fastest safe speed for each participant.
|
3 days Pre operative and 2 weeks post operative
|
|
Anabolic Gene Expression
Prazo: Immediately pre surgery to 2 weeks after surgery
|
Standard procedures including total RNA isolation, cDNA synthesis, cRNA labeling, microarray hybridization and image acquisition will be performed.
Protein content (translation of mTOR, myogenin, and MyoD) will be analyzed.
Total RNA (500 ng) will be reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA), and quantitative PCR will be performed using primer sets for genes of interest, reference genes and iQ SYBR Supermix (Bio-Rad) following manufacturer's protocols.
|
Immediately pre surgery to 2 weeks after surgery
|
|
Muscle Fiber Cross-Sectional Area
Prazo: Immediately pre surgery to 2 weeks after surgery
|
Cross sectional area of individual myofibrils taken from the vastus lateralis muscle using immunohistochemical staining and microscopy to determine change in cross sectional area comparing one hour before surgery to two weeks after surgery
|
Immediately pre surgery to 2 weeks after surgery
|
|
Changes in neural cell adhesion molecule (NCAM) concentration
Prazo: Preop and 2 weeks postop
|
NCAM will be assessed by immunohistochemistry with anti-CD56/NCAM antibody (555514; BD Biosciences, San Jose, CA), followed by goat anti-mouse AF555 (A-21127, ThermoFisher).
NCAM is a multifunctional cell-surface protein that has been shown to be associated with muscle regeneration, through its roles in neurite outgrowth and synaptic plasticity.
NCAM immunohistochemistry will be able to assess 1) denervation status, 2) skeletal muscle response to an intervention, and 3) the capacity for skeletal muscle to improve.
|
Preop and 2 weeks postop
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Victor Cheuy, PhD, University of Colorado, Denver
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo
1 de outubro de 2014
Conclusão Primária (Real)
9 de março de 2020
Conclusão do estudo (Real)
9 de março de 2020
Datas de inscrição no estudo
Enviado pela primeira vez
7 de outubro de 2014
Enviado pela primeira vez que atendeu aos critérios de CQ
30 de outubro de 2014
Primeira postagem (Estimativa)
4 de novembro de 2014
Atualizações de registro de estudo
Última Atualização Postada (Real)
9 de junho de 2021
Última atualização enviada que atendeu aos critérios de controle de qualidade
7 de junho de 2021
Última verificação
1 de junho de 2021
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 14-0905
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .